Grade 3 copanlisib-related AEs included maculopapular rash (n = 2; 15%), aspartate aminotransferase (AST)/alanine aminotransferase (ALT) elevation (n = 1; 7.6%), and anemia (n = 1; 7.6%). This evidence concerns the gene GPT and anemia.